（来源：嘉兴日报） 转自：嘉兴日报 ■记者 闻心玥 通讯员 徐文慧 在平湖市当湖街道的邦芒科技大厦中，运行着一个拥有228家全球直营分公司、覆盖400余座城市、服务 超3万家客户、雇员达100万的人力资源服务企业——邦芒人力集团。 不久前，其运营主体邦芒服务外包有限公司，作为嘉兴唯一的现代服务业企业，入选浙江省第三批"雄 鹰企业"名单。 然而，真正令邦芒人力集团从众多同类企业中脱颖而出的，并非仅是其庞大的规模。一个更具颠覆性的 场景正在发生：在全球某糖果巨头的产线上，工人们正熟练地完成产品最终包装，他们的雇主，不是品 牌方，而是邦芒服务外包有限公司。 从帮人找工作，到今日嵌入制造业肌理的深度赋能者。邦芒"包"下的，从一个个岗位，变成了一段段真 实的制造产线。 管人的企业，怎么帮上制造业的忙？ 邦芒人力集团的故事，始于朴素的"帮忙"。 2007年，为了帮助学生解决求职难题，嘉兴教师余再东创办了邦芒人力集团，并开设了"中固人力资源 网"。那时的邦芒，更像是一个接线员，核心职能是在人与岗位间做信息匹配。 早期，为服务快速扩张的企业，邦芒必须跟随其业务布局，将服务网点铺设到全国各地。这张起初被动 构建的服务网络，如今 ...

Core Insights - The article highlights the successful application of gene therapy for thalassemia by Kanglin Biotechnology, marking a significant breakthrough in the treatment of this genetic disorder in China [1][2] - It emphasizes the evolution of a supportive financial ecosystem for the biopharmaceutical industry in China, which has been crucial for the development and commercialization of innovative therapies [1][5] Group 1: Company Overview - Kanglin Biotechnology has developed gene-modified hematopoietic stem cells that have successfully restored normal hemoglobin levels in patients, eliminating their dependence on blood transfusions [1][2] - The company faced initial skepticism from the capital market due to the high costs and risks associated with biopharmaceutical research, particularly in the early stages of development [2][3] Group 2: Financial Support and Innovation - In 2019, Kanglin Biotechnology received a 5 million yuan credit loan from Zheshang Bank, which was a significant departure from traditional banking practices that typically require physical assets for collateral [3][4] - The financial support allowed Kanglin to continue its research and development, leading to the approval of clinical trials for its thalassemia gene therapy in 2024 [3][4] Group 3: Talent-Centric Financial Models - The "Talent Bank" initiative by Zheshang Bank focuses on providing financial services tailored to high-level talent, which has transformed the traditional credit assessment model from historical performance to evaluating patents and future potential [5][6] - This new financial model has resulted in a significant increase in funding for innovative companies, with over 80.9 billion yuan disbursed through "Talent Loans" in Zhejiang province alone [7][8] Group 4: Collaborative Financial Solutions - The introduction of the "Zheke United Loan" model allows multiple banks to collaborate on funding, reducing individual risk and providing more substantial support to technology enterprises [9][10] - This collaborative approach has led to the disbursement of 10.87 billion yuan in loans to technology companies, with over 30% allocated to biopharmaceutical firms [9][10] Group 5: Broader Implications for the Industry - The financial support has enabled Kanglin Biotechnology to offer its gene therapy at a fraction of the cost of similar international products, demonstrating the impact of financial backing on accessibility and affordability of innovative treatments [11][12] - The success of Kanglin's model is being mirrored in other regions, with cities in the Yangtze River Delta exploring similar financial solutions to support the biopharmaceutical sector [12]

Core Insights - The article discusses the innovative financial services provided by Zheshang Bank to support technology-driven companies in Zhejiang, particularly focusing on the case of Fubao Intelligent Technology Co., Ltd. [3][4][6] Group 1: Financial Innovation - Zheshang Bank has developed a differentiated financial service system called "thousand people, thousand faces," which shifts the evaluation criteria for technology companies from traditional asset-based metrics to talent and innovation-based metrics [7][8] - The bank has established a "Talent Bank" to support high-level talent and technology enterprises, providing tailored financial products to meet their unique needs [7][10] Group 2: Case Study - Fubao Intelligent - Fubao Intelligent experienced significant growth in orders for its intelligent care robots in 2023 but faced financial pressure due to high upfront development costs and lack of collateral for traditional financing [5][6] - Zheshang Bank provided Fubao Intelligent with a 10 million yuan loan to alleviate its liquidity issues, demonstrating a proactive approach to understanding and addressing the financial needs of technology companies [6][8] Group 3: Broader Impact on Technology Sector - The bank's support has enabled Fubao Intelligent to set ambitious sales targets for 2025, with a credit limit approaching 100 million yuan, indicating a strong growth trajectory [6][10] - Zheshang Bank has served over 32,000 technology enterprises, providing financing exceeding 400 billion yuan, showcasing its commitment to fostering innovation and supporting the technology sector [8][11] Group 4: Future Directions - The bank is expanding its services to include cross-border financial solutions for technology companies looking to enter international markets, reflecting a growing trend in the industry [11][12] - Zheshang Bank aims to transform from a traditional funding provider to an ecosystem builder, emphasizing long-term partnerships and comprehensive service offerings for technology innovation [12]